InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
14
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Townsend Adam J., Responsable Commercial. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 38 reports have been recorded. Split: 0 buy · 14 sells. Total volume traded: €9.2m. Activity tracked since 21 January 2022. The latest transaction was disclosed on 29 January 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Townsend Adam J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations38 total
695 shares@ US$29.52360.2% of flowCommon StockSEC:0001127602-25-002387:0
3,323 shares@ US$30.42550.8% of flowCommon StockSEC:0001127602-25-001845:0
2,201 shares@ US$29.95820.5% of flowCommon StockSEC:0001127602-25-001629:0
2,685 shares@ US$28.70210.6% of flowCommon StockSEC:0001127602-25-001203:0
1,148 shares@ US$67.76690.6% of flowCommon StockSEC:0001127602-24-004734:0
906 shares@ US$64.13820.4% of flowCommon StockSEC:0001127602-24-002753:0
3,413 shares@ US$64.9961.7% of flowCommon StockSEC:0001127602-24-001960:0
23,748 shares0Common StockSEC:0001127602-24-001434:0
110,000 shares@ US$15.0912.5% of flowCommon StockSEC:0001127602-23-028964:0
67,557 shares@ US$60.501930.9% of flowCommon StockSEC:0001127602-23-028964:1
42,443 shares@ US$61.305219.7% of flowCommon StockSEC:0001127602-23-028964:2
5,000 shares@ US$15.090.6% of flowCommon StockSEC:0001127602-23-014500:0
5,000 shares@ US$15.090.6% of flowCommon StockSEC:0001127602-23-012593:0
5,000 shares@ US$15.090.6% of flowCommon StockSEC:0001127602-23-009314:0
5,000 shares@ US$63.842.5% of flowCommon StockSEC:0001127602-23-009314:1
9,886 shares0Common StockSEC:0000899243-23-005779:0
782 shares@ US$51.210.3% of flowCommon StockSEC:0001127602-23-005169:0
5,000 shares@ US$15.090.6% of flowCommon StockSEC:0001127602-23-003582:0
551 shares@ US$52.770.2% of flowCommon StockSEC:0001127602-23-002691:0
1,912 shares@ US$52.050.8% of flowCommon StockSEC:0001127602-23-002140:0
27,488 shares0Common StockSEC:0001127602-23-001501:0
5,000 shares@ US$15.090.6% of flowCommon StockSEC:0001127602-23-001004:0
5,000 shares@ US$15.090.6% of flowCommon StockSEC:0000899243-22-037834:0
5,000 shares@ US$15.090.6% of flowCommon StockSEC:0000899243-22-035276:0
5,000 shares@ US$15.090.6% of flowCommon StockSEC:0001127602-22-023726:0
25 of 38 declarations
About Townsend Adam J.
Townsend Adam J. is Chief Commercial Officer at Apellis Pharmaceuticals, Inc. (XNAS). He has 38 filings in total, and in the recent filing sample covered here, the transactions are entirely sales, totaling EUR 9,192,180 between 2022-01-25 and 2025-01-30.
